Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain

Cardiology

Volumn 91, Issue 1, 1999, Pages 50-55

  Serebruany, Victor L ^a   Murugesan, Selva R ^a   Pothula, Anitha ^a   Semaan, Husam ^a   Gurbel, Paul A ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Acute myocardial infarction; Chest pain; Emergency medicine; Osteonectin; P selectin; PECAM 1

Indexed keywords

CD31 ANTIGEN; OSTEONECTIN; PADGEM PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THORAX PAIN;

AGED; ANTIGENS, CD31; BIOLOGICAL MARKERS; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OSTEONECTIN; P-SELECTIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0033001681     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006876     Document Type: Article

References (53)

1. Roberts R: Early diagnosis of myocardial infarction with MB CK isoforms. Clin Chim Acta 1998;272:33-45.
2. Millane T, Hearing SD, Jones PE, Brooks NH: Two ECGs and a history: A guide to early hospital discharge of patients with 'chest pain? cause'. J R Coll Phys [Lond] 1998;32:122-124.
3. Hedges JR, Young GP, Henkel GF, Gibler WB, Green TR, Swanson JR: Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 1992;21:1445-1450.
4. de Winter RJ, Koster RW, Sturk A, Sanders GT: Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-3407.
5. Kontos MC, Arrowood JA, Paulsen WH, Nixon JV: Early echocardiography can predict cardiac events in emergency department patients with chest pain. Ann Emerg Med 1998;31:550-557.
6. Mair J: Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. Clin Chim Acta 1998;272:79-86.
7. Davies MJ, Thomas AC, Knapman PA, Hangarter JR: Intramyocardial platelet aggregation in patients with acute myocardial infarction suffering sudden ischemic cardiac death. Circulation 1986;73:418-427.
8. Opie LH: New concepts regarding events that lead to myocardial infarction. Cardiovasc Drugs Therap 1995;9(suppl 3):479-487.
9. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512.
10. Tedder TF, Steeber DA, Chen A, Engel P: The selectins: Vascular adhesion molecules. FASEB J 1995;9:866-873.
11. Newman PJ, Berndt MC, Gorsky J, White GC, Paddock LS, Muller WA: PECAM-1 (CD 31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-1223.
12. Muller WA, Berman ME, Newman PJ, DeLisser HM, Albelda SM: A heterophylic adhesion mechanisms for platelet/endothelial adhesion molecule 1 (CD 31). J Exp Med 1992;175: 1401-1404.
13. Cramer EM, Berger G, Berndt MC: Platelet alpha-granule and plasma membrane share two new components: CD9 and PECAM-1. Blood 1994;84:1722-1730.
14. Carlos TM, Harlan JM: Leukocyte-endothelial cell adhesion molecules. Blood 1994;84:2069-2101.
15. Lefer AM, Weyrich AS, Buerke M: Role of selecting, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994;28:289-294.
16. Romberg RW, Werness PG, Lollar P, Riggs BL, Mann KG: Isolation and characterization of native adult osteonectin. J Biol Chem 1985; 260:2728-2733.
17. Breton-Gorius J, Clezardin P, Guichard J, Debili N, Malaval L, Vainchenker W, Cramer EM, Delmas PD: Localization of platelet osteonectin at the internal face of the α-granule membranes in platelets and megakaryocytes. Blood 1992;79:936-941.
18. Malaval L, Darbouret B, Peaudat C, John JP, Delmas P: Intertissular variations in osteonectin: A monoclonal antibody directed to bone osteonectin shows reduced affinity for platelet osteonectin. J Bone Miner Res 1991;6:315-321.
19. Kelm RJ Jr, Mann KG: Human platelet osteonectin: release, surface expression, and partial characterization. Blood 1990;75:1105-1113.
20. Gumina RJ, Schultz JE, Yao Z, Kenny D, Warltier DC, Newman PJ, Gross GJ: Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 1996;94:3327-3333.
21. Murohara T, Delyani JA, Albelda SM, Lefer AM: Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 1996;156:3550-3557.
22. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM: In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-2629.
23. Ueyama T, Ikeda H, Haramaki N, Kuwano K, Imaizumi T: Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation 1997;95:1554-1559.
24. Kleiman NS, Ohman EM, Califf RM, George BS, Kereiakes D, Aguine FV, Weisman H, Schaible T, Topol EJ: Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study. J Am Coll Cardiol 1993;22:381-389.
25. Lefer AM, Campbell B, Shin YK: Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion. J Mol Cell Cardiol 1998;12:2561-2566.
26. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, Sugi K, Imaizumi T: Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995;92:1693-1696.
27. Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ: Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens 1998; 16:45-50.
28. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Suefuji H, Sumida H, Okumura K: Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92:1726-1730.
29. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, Koga Y, Toshima H: Soluble form of P-selectin in patients with acute myocardial infarction. Coron Artery Dis 1994; 5:515-518.
30. Gurbel PA, Serebruany VL: Myths and realities of plasma P-selectin levels in patients with acute myocardial infarction. Thromb Res 1997;88:343-344.
31. Sakurai S, Inoue A, Koh CS, Owa M, Yanagisawa N: Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention. Vase Med 1997;2:163-168.
32. Bihour C, Durrieu-Jais C, Besse P, Nurden P, Nurden AT: Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction. Blood Coag Fibrinol 1995;6:395-410.
33. Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Carpo C, Ohman EM, Topol EJ, for the GUSTO III Investigators: Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. The GUSTO III Platelet Study. J Am Coll Cardiol 1998;31:1466-1473.
34. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK: Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med 1993;121:579-587.
35. Gurbel PA, Dalesandro MR, Serebruany VL: Effects of reteplase and alteplase on soluble PECAM-1 and P-selectin in patients with acute myocardial infarction. Thromb Haemost 1998; 80:725.
36. Serebruany VL, Gurbel PA: Effect of thrombolytic therapy on the plasma concentration and platelet expression of the platelet/endothelial cell adhesion molecule-1 in patients with acute myocardial infarction. Arterioscl Thromb Vase Biol 1999;19:153-158.
37. Pumphrey CW, Dawes J: Plasma beta-thromboglobulin as a measure of platelet activity: Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction. Am J Cardiol 1982;50:1258-1261.
38. Hughes A, Daunt S, Vass G, Wickes J: In vivo platelet activation following myocardial infarction and acute coronary ischemia. Thromb Haemost 1982;48:133-135.
39. Hata T, Kawamura T, Inada K, Fujiwaki R, Ariyuki Y, Hata K, Kitao M: Cord blood cytokines and soluble adhesion molecules in vaginal and cesarean delivered neonates. Gynecol Obstet Invest 1996;42:102-104.
40. Rubenfire M, Blevins RD, Barnhart M, Housholder S, Selik N, Mammen EF: Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1986;57:657-660.
41. Verheugt FW, Serruys PW, van Vliet H, Spijkers A, Hugenholtz PG: Intracoronary platelet release in patients with and without coronary artery disease. Thromb Haemost 1983;49:28-31.
42. Rao AK, Mintz PD, Lavine SJ, Bove AA, McDonough MT, Spann JF, Walsh PN: Coagulant activities of platelets in coronary artery disease. Circulation 1984;69:15-21.
43. Serebruany VL, Gurbel PA, Shustov AR, Dalesandro M, Gumbs SI, Grablutz BS, Bahr RD, Ohman EM, Topol EJ, for the GUSTO-III Investigators: Depressed platelet status in a patient with hemorrhagic stroke following thrombolysis for acute myocardial infarction. Stroke 1998;29:235-238.
44. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ: Heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction. Am Heart J 1998;136:398-405.
45. Shimomura H, Ogawa H, Arai H, Moriyama Y, Takazoe K, Hirai N, Kaikita K, Hiroshima O, Misumi K, Soejima N, Nishiyama K, Yasue H: Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol 1998;81:397-400.
46. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K: The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group. Coron Artery Dis 1994;5:339-345.
47. Clezardin P, Malaval L, Ehrensperger A-S, Delmas PD, Dechavanne M, McGregor JL: Complex formation of human thrombospondin and osteonectin. Eur J Biochem 1988;175:275-281.
48. Muller WA: The use of anti-PECAM reagents in the control of inflammation. Agents Actions 1995;46(suppl):147-157.
49. Ostrovsky L, King AJ, Bond S, Mitchell D, Lorant DE, Zimmerman GA, Larsen R, Niu XF, Kubes P: A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood 1998;91:3028-3036.
50. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM: Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 1997;173:327-334.
51. Mannaioni PF, Di Bello MG, Masini E: Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997;46:4-18.
52. Schuermann GM, Aber-Bishop AE, Facer P, Lee JC, Rampton DS, Dore CJ, Polak JM: Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol 1993;94:341-347.
53. Goke M, Hoffmann JC, Evers J, Kruger H, Manns MP: Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 1997;32:480-486.